Andrew Kaplan Purchases 8,398,438 Shares of Kailera Therapeutics (NASDAQ:KLRA) Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Andrew Kaplan purchased 8,398,438 shares of the firm’s stock in a transaction dated Monday, April 20th. The stock was purchased at an average cost of $16.00 per share, with a total value of $134,375,008.00. Following the acquisition, the director directly owned 26,255,581 shares in the company, valued at $420,089,296. This trade represents a 47.03% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Kailera Therapeutics Stock Down 5.3%

Shares of KLRA traded down $1.39 during mid-day trading on Monday, hitting $24.61. 1,340,343 shares of the company’s stock were exchanged. Kailera Therapeutics, Inc. has a 52 week low of $23.69 and a 52 week high of $28.23.